Opinion

Video

Optimizing Care of Patients With Advanced Prostate Cancer: Conclusion

Author(s):

Eleni Efstathiou, MD, PhDSean Collins, MD, PhD

Summarizes the main points and benefits of multidisciplinary prostate cancer care.

Related Videos
Fred Saad, CQ, MD, FRCS, FCAHS
2 KOLs are featured in this series.
2 KOLs are featured in this series.
A panel of 3 experts on nasopharyngeal carcinoma
Fred Saad, CQ, MD, FRCS, FCAHS
Alicia Morgans, MD, MPH
Related Content
Neal Shore, MD, FACS, steering committee chair, medical director, Carolina Urologic Research Center
October 9th 2024

Apalutamide Demonstrates Real-World OS Benefit vs Enzalutamide in mCSPC

Neeraj Agarwal, MD
July 17th 2023

FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC

Neeraj Agarwal, MD, FASCO
October 8th 2024

PARP1-Selective Inhibitors Generate Excitement in Solid Tumors

Andrew J. Armstrong, MD, MSc
June 15th 2023

FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

Bertram Yuh, MD, MISM, MSHCPM
September 30th 2024

Prostate Cancer Awareness Efforts Target Patient Education, Treatment Access, and Survivorship Care

Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
September 26th 2024

sNDA for Darolutamide Plus ADT in mHSPC Submitted for FDA Review